Bioreactor system and method of enhancing functionality of muscle cultured in vitro

Patent metadata

Field	Value
Publication number	US-9757225-B2
Application number	US-201615298382-A
Country	US
Kind code	B2
Filing date	Oct 20, 2016
Priority date	Apr 15, 2005
Publication date	Sep 12, 2017
Grant date	Sep 12, 2017

Abstract

A method of producing organized skeletal muscle tissue from precursor muscle cells in vitro comprises: (a) providing precursor muscle cells on a support in a tissue media; then (b) cyclically stretching and relaxing the support at least twice along a first axis during a first time period; and then (c) optionally but preferably maintaining the support in a substantially static position during a second time period; and then (d) repeating steps (b) and (c) for a number of times sufficient to enhance the functionality of the tissue formed on the support and/or produce organized skeletal muscle tissue on the solid support from the precursor muscle cells.

First claim

That which is claimed is:

1. A method of reconstructing a muscle in a subject in need thereof, comprising implanting muscle tissue in said subject in an orientation effective to reconstruct said muscle, wherein said muscle tissue is produced by a process comprising:
(a) providing a decellularized tissue support in a tissue media in a bioreactor, said support comprising mammalian precursor muscle cells; then
(b) cyclically stretching and relaxing said support at least twice along a first axis during a first time period; and then
(c) maintaining said support in a substantially static position during a second time period; and then
(d) repeating steps (b) and (c) for a number of times sufficient to produce said muscle tissue on said support from said precursor muscle cells, wherein repeating steps (b) and (c) is carried out for a time of up to two weeks and results in the muscle tissue having unidirectional orientation, and
wherein said muscle tissue is further characterized by enhancing cellular organization, contractile function and tissue formation upon said implanting.

2. A method of building soft tissue in a subject in need thereof, comprising implanting muscle tissue in said subject in an orientation effective to build soft tissue, wherein said muscle tissue is produced by a process comprising:
(a) providing a decellularized tissue support in a tissue media in a bioreactor, said support comprising mammalian precursor muscle cells; then
(b) cyclically stretching and relaxing said support at least twice along a first axis during a first time period; and then
(c) maintaining said support in a substantially static position during a second time period; and then
(d) repeating steps (b) and (c) for a number of times sufficient to produce said muscle tissue on said support from said precursor muscle cells, wherein repeating steps (b) and (c) is carried out for a time of up to two weeks and results in the muscle tissue having unidirectional orientation, and
wherein said muscle tissue is further characterized by enhancing cellular organization, contractile function and tissue formation upon said implanting.

3. The method of claim 1 , wherein said subject has a traumatic injury of an arm or leg.

4. The method of claim 1 , wherein said subject is in need of partial or total reconstruction of a damaged muscle of the face, hand, foot, arm, leg, back or trunk.

5. The method of claim 1 , wherein said repeating of steps (b) and (c) is carried out for a time of five days to one week.

6. The method of claim 1 , wherein said muscle tissue is suturable and is 1 to 50 cm in length.

7. The method of claim 1 , wherein said muscle tissue has a volume of at least 1 cubic centimeter.

8. The method of claim 1 , wherein said muscle tissue is allogenic with respect to the subject.

9. The method of claim 1 , wherein said precursor muscle cells are human cells.

10. The method of claim 1 , wherein said support is decellularized smooth muscle tissue.

11. The method of claim 1 , wherein the support is decellularized skeletal muscle tissue.

12. The method of claim 2 , wherein the soft tissue is at an interface between an amputated limb and a prosthetic device.

13. The method of claim 2 , wherein said repeating of steps (b) and (c) is carried out for a time of five days to one week.

14. The method of claim 2 , wherein said muscle tissue is suturable and is 1 to 50 cm in length.

15. The method of claim 2 , wherein said muscle tissue has a volume of at least 1 cubic centimeter.

16. The method of claim 2 , wherein said muscle tissue is allogenic with respect to the subject.

17. The method of claim 2 , wherein said precursor muscle cells are human cells.

18. The method of claim 2 , wherein said support is decellularized smooth muscle tissue.

19. The method of claim 2 , wherein the support is decellularized skeletal muscle tissue.

Assignees

• Univ Wake Forest Health Sciences

Inventors

• Yoo James
• Stitzel Jr Joel D
• Atala Anthony
• Christ George

Classifications

• C12M35/04

  Mechanical means, e.g. sonic waves, stretching forces, pressure or shear stimuli · CPC title

• A61F2/08 Primary

  Muscles; Tendons; Ligaments · CPC title

• A61L2430/34

  for soft tissue reconstruction · CPC title

• A61L27/367

  Muscle tissue, e.g. sphincter · CPC title

• C12N2539/00

  Supports and/or coatings for cell culture characterised by properties · CPC title